Literature DB >> 3781335

Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis.

A Braillon, P Cales, D Valla, D Gaudy, P Geoffroy, D Lebrec.   

Abstract

Systemic and splanchnic haemodynamics were studied in patients with cirrhosis who had been classified in three groups (A, B, and C) according to the degree of liver failure (modified Pugh's classification). In patients of group A, cardiac index was significantly lower than that of group C and systemic vascular resistance was higher, but not significantly so, than that of patients with liver failure. Wedged hepatic venous pressure was significantly lower in the former group than in the latter. In patients in group B, corresponding values fell between those of groups A and C. Azygos blood flow averaged 0.477 +/- 0.242 l/min (mean +/- SD) in group A and it was significantly lower than in groups B and C (0.642 +/- 0.224 and 1.061 +/- 0.476 l/min, respectively). In the three groups, acute administration of propranolol induced statistically significant changes in systemic and splanchnic haemodynamics. In patients of group C but not of group B, the mean value of azygos blood flow after propranolol remained significantly higher than in group A. Moreover, the fraction of azygos blood flow to cardiac output decreased in groups A and B while slightly increased in group C. This study shows that in patients with cirrhosis, the degree of liver failure may be a determinant for the haemodynamic responses to drugs acting on portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3781335      PMCID: PMC1433865          DOI: 10.1136/gut.27.10.1204

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Observations on the influence of medical therapy on portal hypertension in hepatic cirrhosis.

Authors:  C M LEEVY; M ZINKE; J BABER; W Y CHEY
Journal:  Ann Intern Med       Date:  1958-10       Impact factor: 25.391

2.  Effect of increased intraabdominal pressure on hepatic hemodynamics in patients with chronic liver disease and portal hypertension.

Authors:  S Iwatsuki; T B Reynolds
Journal:  Gastroenterology       Date:  1973-08       Impact factor: 22.682

3.  Hyperdynamic states and the physiologic determinants of survival in patients with cirrhosis and portal hypertension.

Authors:  J H Siegel; R M Goldwyn; E J Farrell; P Gallin; H P Friedman
Journal:  Arch Surg       Date:  1974-03

4.  Propranolol in decompensated alcoholic cirrhosis.

Authors:  J C Colman; G L Jennings; A J McLean; P R Mignot; F J Dudley
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

5.  Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure.

Authors:  T D Boyer; D R Triger; M Horisawa; A G Redeker; T B Reynolds
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

6.  Pathogenesis of hepatic encephalopathy and hyperdynamic syndrome in cirrhosis. Role of false neurotransmitters.

Authors:  A Nespoli; G Bevilacqua; C Staudacher; N Rossi; F Salerno; M R Castelli
Journal:  Arch Surg       Date:  1981-09

7.  Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure.

Authors:  D Lebrec; G Goldfarb; C Degott; B Rueff; J P Benhamou
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

8.  The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

Authors:  D Lebrec; P Hillon; C Muńoz; G Goldfarb; O Nouel; J P Benhamou
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

9.  Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics.

Authors:  J H Henriksen; N J Christensen; H Ring-Larsen
Journal:  Clin Physiol       Date:  1981-06

10.  Circulating levels of vasoactive intestinal polypeptide in liver disease.

Authors:  S Hunt; C A Vaamonde; T Rattassi; G Berian; S I Said; S Papper
Journal:  Arch Intern Med       Date:  1979-09
View more
  32 in total

Review 1.  Pathophysiology and epidemiology of portal hypertension.

Authors:  H Okumura; T Aramaki; Y Katsuta
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 2.  Renal dysfunction in cirrhosis: diagnosis, treatment and prevention.

Authors:  Elaine Yeung; Elaine Yong; Florence Wong
Journal:  MedGenMed       Date:  2004-12-02

Review 3.  Duplex Doppler ultrasound examination of the portal venous system: an emerging novel technique for the estimation of portal vein pressure.

Authors:  Ashwani K Singal; Masood Ahmad; Roger D Soloway
Journal:  Dig Dis Sci       Date:  2009-07-23       Impact factor: 3.199

4.  Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding.

Authors:  D Patch; A Armonis; C Sabin; K Christopoulou; L Greenslade; A McCormick; R Dick; A K Burroughs
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 5.  Vasodilatation associated with hepatocellular disease: relation to functional organ failure.

Authors:  S Sherlock
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

6.  Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.

Authors:  L A Colombato; L Spahr; J P Martinet; M P Dufresne; M Lafortune; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

Review 7.  Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients.

Authors:  Suehana Rahman; Susan V Mallett
Journal:  World J Hepatol       Date:  2015-03-27

8.  Pressure of intraoesophageal varices assessed by fine needle puncture: its relation to endoscopic signs and severity of liver disease in patients with cirrhosis.

Authors:  G Kleber; T Sauerbruch; G Fischer; G Paumgartner
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

9.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

Review 10.  Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.

Authors:  Virginia Hernandez-Gea; Fanny Turon; Annalisa Berzigotti; Augusto Villanueva
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.